包括Marcum财富有限责任公司在内的机构投资者增加了对Vertex制药公司和CVS保健公司的股权。 Institutional investors, including Marcum Wealth LLC, increased stakes in Vertex Pharmaceuticals and CVS Health.
马库姆财富有限公司在Vertex制药业的股份增加了2.2%,现在拥有1 204股,价值560 000美元。 Marcum Wealth LLC increased its stake in Vertex Pharmaceuticals by 2.2%, now owning 1,204 shares valued at $560,000. 其他机构投资者也增加了他们的地位。 Other institutional investors also added to their positions. Vertex报告,Q2净损失为每股12.83美元,收入为26.5亿美元。 Vertex reported a Q2 net loss of $12.83 per share, with $2.65 billion in revenue. CVS Health 从 Pine Haven Investment Counsel 持有的股票增加了 8.4%，超过了每股 1.83 美元的收益预期。 CVS Health saw an 8.4% increase in holdings from Pine Haven Investment Counsel, surpassing earnings estimates with $1.83 per share. 机构投资者拥有CVS股票的80.66%。 Institutional investors own 80.66% of CVS stock.